Literature DB >> 2156075

Hydrolytic enzyme production by Clostridium difficile and its relationship to toxin production and virulence in the hamster model.

S V Seddon1, I Hemingway, S P Borriello.   

Abstract

Thirty isolates of Clostridium difficile expressing different degrees of toxigenicity and virulence in an animal model were assayed for the production of chondroitin-4-sulphatase, hyaluronidase, heparinase, collagenase and protease. All strains demonstrated some hydrolytic enzyme activity. There was no direct correlation between toxigenic status, or virulence, and hydrolytic enzyme production. However, all five strains known to be highly virulent in the hamster model had hyaluronidase, chondroitin-4-sulphatase and collagenase activity whereas only three of five toxigenic but poorly virulent strains had these activities, the collagenase activity being weak in all three cases. The only two proteolytic strains are also highly virulent. The potential tissue damaging properties of these hydrolytic enzymes may help to explain the differences in virulence of C. difficile strains seen in the Syrian hamster model of antibiotic-associated colitis, and may contribute to the spectrum of disease seen in man. It is also possible that chondroitin-4-sulphatase, hyaluronidase and collagenase activity may release essential nutrients, promoting establishment of C. difficile in the gut.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156075     DOI: 10.1099/00222615-31-3-169

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  19 in total

1.  Crystallization and preliminary crystallographic analysis of recombinant hyaluronate lyase from Streptococcus suis.

Authors:  Abdul Hamid Khan; Youssef Mohamed Mohamed Omar; Mohammad Azam Kakar; Nasrullah Bangulzai
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-05-25

2.  Cwp22, a novel peptidoglycan cross-linking enzyme, plays pleiotropic roles in Clostridioides difficile.

Authors:  Duolong Zhu; Jessica Bullock; Yongqun He; Xingmin Sun
Journal:  Environ Microbiol       Date:  2019-06-28       Impact factor: 5.491

3.  Characterization of a cell surface protein of Clostridium difficile with adhesive properties.

Authors:  A J Waligora; C Hennequin; P Mullany; P Bourlioux; A Collignon; T Karjalainen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 4.  Optimising gut colonisation resistance against Clostridium difficile infection.

Authors:  S Yuille; W G Mackay; D J Morrison; M C Tedford
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-09       Impact factor: 3.267

Review 5.  Preparing the Bowel for Surgery: Learning from the Past and Planning for the Future.

Authors:  John C Alverdy; Neil Hyman; Jack Gilbert; James N Luo; Monika Krezalek
Journal:  J Am Coll Surg       Date:  2017-05-19       Impact factor: 6.113

6.  Transcription and analysis of polymorphism in a cluster of genes encoding surface-associated proteins of Clostridium difficile.

Authors:  Marie-Pierre Savariau-Lacomme; Carole Lebarbier; Tuomo Karjalainen; Anne Collignon; Claire Janoir
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

7.  Morphological and genetic diversity of temperate phages in Clostridium difficile.

Authors:  Louis-Charles Fortier; Sylvain Moineau
Journal:  Appl Environ Microbiol       Date:  2007-09-21       Impact factor: 4.792

Review 8.  Clostridium difficile-associated diarrhea in adults.

Authors:  Susan M Poutanen; Andrew E Simor
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

9.  Cloning of a genetic determinant from Clostridium difficile involved in adherence to tissue culture cells and mucus.

Authors:  T Karjalainen; M C Barc; A Collignon; S Trollé; H Boureau; J Cotte-Laffitte; P Bourlioux
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.

Authors:  S P Borriello; B W Wren; S Hyde; S V Seddon; P Sibbons; M M Krishna; S Tabaqchali; S Manek; A B Price
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.